COPD Clinical Trials in New York, NY

19 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease	Phase 3	AstraZeneca	<1 mi
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital	N/A	Fisher and Paykel Healthcare	<1 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)	Phase 3	Hoffmann-La Roche	<1 mi
SPIROMICS Study of Early COPD Progression (SOURCE)	—	University of Massachusetts, Worcester	<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD	Phase 2	Johns Hopkins University	<1 mi
Lung Microbiome and Inflammation in Early COPD	—	NYU Langone Health	<1 mi
Evaluation Of The Lung Microbiome In NTM Bronchiectasis	—	NYU Langone Health	<1 mi
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.	N/A	Observational and Pragmatic Research Institute	<1 mi
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies	—	Weill Medical College of Cornell University	<1 mi
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease	Phase 3	Hoffmann-La Roche	<1 mi
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
WTC Chest CT Imaging Archive	—	Icahn School of Medicine at Mount Sinai	<1 mi
PiMZ Longitudinal Cohort (PiMZ Logic)	—	Columbia University	<1 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	11 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)	Phase 3	AstraZeneca	13 mi
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease	N/A	University of Alabama at Birmingham	33 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening	—	Freenome Holdings Inc.	34 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD	Phase 2	Verona Pharma plc	35 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease	Phase 2	AstraZeneca	37 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.